Impact of Fc{gamma}RIIa-Fc{gamma}RIIIa polymorphisms and KRAS mutations on the clinical outcome of patients with metastatic colorectal cancer treated with cetuximab plus irinotecan. (Q46151045)
Jump to navigation
Jump to search
scientific article published on 21 January 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Impact of Fc{gamma}RIIa-Fc{gamma}RIIIa polymorphisms and KRAS mutations on the clinical outcome of patients with metastatic colorectal cancer treated with cetuximab plus irinotecan. |
scientific article published on 21 January 2009 |
Statements
Impact of Fc{gamma}RIIa-Fc{gamma}RIIIa polymorphisms and KRAS mutations on the clinical outcome of patients with metastatic colorectal cancer treated with cetuximab plus irinotecan (English)
Frédéric Bibeau
Evelyne Lopez-Crapez
Frédéric Di Fiore
Simon Thezenas
France Blanchard
Aude Lamy
Frédérique Penault-Llorca
Thierry Frébourg
Pierre Michel
Jean-Christophe Sabourin
Florence Boissière-Michot
21 January 2009